---
title: "Understanding the Market | JOLIMARK fell over 30% after surging 3 times in the previous two days, expecting a maximum loss of 40 million yuan in the first half of the year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252792113.md"
description: "JOLIMARK fell over 30%, as of the time of writing, down 30.49%, priced at HKD 0.155, with a trading volume of HKD 3.6113 million. In terms of news, JOLIMARK was briefly suspended yesterday afternoon and continued to decline after resuming trading this morning. It is worth noting that the stock had surged significantly in the previous two trading days, with a cumulative increase of up to 346%. JOLIMARK announced that compared to a loss of RMB 43.495 million in the same period last year, the group expects to incur a loss of RMB 35 million to 40 million in the first half of 2025. The main reasons for the loss are due to a decline in printer demand, asset impairment provisions, and the lack of large-scale sales of medical products"
datetime: "2025-08-13T06:05:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252792113.md)
  - [en](https://longbridge.com/en/news/252792113.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252792113.md)
---

# Understanding the Market | JOLIMARK fell over 30% after surging 3 times in the previous two days, expecting a maximum loss of 40 million yuan in the first half of the year

According to Zhitong Finance APP, JOLIMARK (02028) has fallen over 30%, currently down 30.49% to HKD 0.155, with a trading volume of HKD 3.6113 million.

In terms of news, JOLIMARK was briefly suspended yesterday afternoon and continued to decline after resuming trading this morning. It is worth noting that the stock had surged significantly in the previous two trading days, with a cumulative increase of up to 346%. JOLIMARK announced that compared to a loss of RMB 43.495 million in the same period last year, the group expects to incur a loss of RMB 35 million to 40 million in the first half of 2025. The main reasons for the loss are the decline in printer demand, asset impairment provisions, and the lack of large-scale sales of medical products

### Related Stocks

- [02028.HK](https://longbridge.com/en/quote/02028.HK.md)

## Related News & Research

- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [Rising Bond Yields Weigh on Stocks](https://longbridge.com/en/news/286939009.md)
- [Trump Dodges On Whether Violent Jan. 6 Rioters Should Get Payouts From New Fund](https://longbridge.com/en/news/286826873.md)
- [Kevin Warsh will have a hard time navigating the political minefield as Fed chair: Scott Nations](https://longbridge.com/en/news/286856758.md)
- [Ramp CEO Is Watching IPO Pipeline Closely As SpaceX, Anthropic, And OpenAI Loom](https://longbridge.com/en/news/286963150.md)